CAFs stimulate EMT in gastric cancer cells in a microRNA-214-dependent manner—it induces tumor-promoting ability of CAFs through fibroblast growth factor 9 (FGF9) targeting [255,256]. The gene discussed is FGF9; the disease is neoplasm.